148 related articles for article (PubMed ID: 9294970)
1. Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex.
Lanza M; Bonnafous C; Colombo S; Revel L; Makovec F
Neuropharmacology; 1997 Aug; 36(8):1057-64. PubMed ID: 9294970
[TBL] [Abstract][Full Text] [Related]
2. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
3. DL-tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy.
Lunn WH; Schoepp DD; Calligaro DO; Vasileff RT; Heinz LJ; Salhoff CR; O'Malley PJ
J Med Chem; 1992 Nov; 35(24):4608-12. PubMed ID: 1361579
[TBL] [Abstract][Full Text] [Related]
4. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
[TBL] [Abstract][Full Text] [Related]
5. Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide.
Kiewert C; Kumar V; Hildmann O; Hartmann J; Hillert M; Klein J
Brain Res; 2008 Mar; 1201():143-50. PubMed ID: 18325484
[TBL] [Abstract][Full Text] [Related]
6. HA-966 acts at a modulatory glycine site to inhibit N-methyl-D-aspartate-evoked neurotransmitter release.
Keith RA; Mangano TJ; Meiners BA; Stumpo RJ; Klika AB; Patel J; Salama AI
Eur J Pharmacol; 1989 Aug; 166(3):393-400. PubMed ID: 2572428
[TBL] [Abstract][Full Text] [Related]
7. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
Pittaluga A; Pattarini R; Raiteri M
Eur J Pharmacol; 1995 Jan; 272(2-3):203-9. PubMed ID: 7713164
[TBL] [Abstract][Full Text] [Related]
8. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
9. Allosteric interactions and modulator requirement for NMDA receptor function.
Marvizón JC; Baudry M
Eur J Pharmacol; 1994 Oct; 269(2):165-75. PubMed ID: 7531646
[TBL] [Abstract][Full Text] [Related]
10. Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors.
Martin DC; Plagenhoef M; Abraham J; Dennison RL; Aronstam RS
Biochem Pharmacol; 1995 Mar; 49(6):809-17. PubMed ID: 7702639
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
12. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
13. The "kynurenate test", a biochemical assay for putative cognition enhancers.
Pittaluga A; Vaccari D; Raiteri M
J Pharmacol Exp Ther; 1997 Oct; 283(1):82-90. PubMed ID: 9336311
[TBL] [Abstract][Full Text] [Related]
14. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
Mennini T; Mancini L; Reggiani A; Trist D
Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
[TBL] [Abstract][Full Text] [Related]
15. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices.
Pittaluga A; Pattarini R; Andrioli GC; Viola C; Munari C; Raiteri M
J Pharmacol Exp Ther; 1999 Jul; 290(1):423-8. PubMed ID: 10381808
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures.
Smith KJ; Self RL; Butler TR; Mullins MM; Ghayoumi L; Holley RC; Littleton JM; Prendergast MA
Brain Res; 2007 Jul; 1157():74-80. PubMed ID: 17524372
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
Pittaluga A; Raiteri M
J Pharmacol Exp Ther; 1992 Oct; 263(1):327-33. PubMed ID: 1357159
[TBL] [Abstract][Full Text] [Related]
18. NMDA receptor activation by spermine requires glutamate but not glycine.
Marvizón JC; Baudry M
Eur J Pharmacol; 1993 Jan; 244(1):103-4. PubMed ID: 8093599
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings.
Pittaluga A; Raiteri M
Eur J Neurosci; 1994 Nov; 6(11):1743-9. PubMed ID: 7874313
[TBL] [Abstract][Full Text] [Related]
20. Endogenous glycine modulates N-methyl-D-aspartate-evoked release of adenosine and [3H]noradrenaline from rat cortical slices.
Craig CG; White TD
Eur J Pharmacol; 1991 May; 197(1):1-7. PubMed ID: 1832638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
